Penpulimab, identified by the specific CAS number 2350298-92-7, represents a cutting-edge therapeutic antibody currently undergoing assessment for its potential in malignancy treatment. This biological agent is https://oisidwfz037281.wikiannouncement.com/10453088/penpulimab_a_deep_investigation_into_the_2350298_92_7_immunoglobulin